Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab 2024-02-09 11:22
Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe 2023-12-01 03:53
Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule 2023-09-06 19:00
1